Skip to main content

Table 2 Cochrane Risk of Bias Table for RCTs

From: Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis

Cochrane risk of bias tool criteria

 

Selection bias

Performance bias

Detection bias

Attrition bias

Reporting bias

Other bias

Total

 

Study

Random Sequence Generation

Allocation Concealment

Blinding of Participants & Personnel

Blinding of Outcome Assessment

Incomplete Outcome Data

Selective Reporting

Other Sources of Bias

 

[28]

2

2

2

2

2

2

2

14

[30]

1

1

2

2

2

2

2

12

[10]

2

2

2

2

2

2

2

14

[31]

2

2

2

2

2

2

2

14

[37]

2

2

2

2

2

2

2

14

[29]

2

2

2

2

2

2

2

14

[32]

2

2

2

2

2

2

2

14

[36]

2

2

2

2

2

2

2

14

[26]

2

2

2

2

2

2

2

14

[33]

1

1

2

2

2

2

2

12

[49]

2

2

2

2

2

2

2

14

[34]

2

2

2

2

0

2

2

12

[35]

2

2

2

2

2

2

2

14

[27]

2

2

2

2

2

2

2

14

  1. 0 = high risk
  2. 1 = unclear
  3. 2 = low risk